Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 331

1.

Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B, Schild SE.

Oral Oncol. 2016 Jun;57:40-5. doi: 10.1016/j.oraloncology.2016.04.003. Epub 2016 Apr 25.

PMID:
27208843
2.

A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.

Rades D, Kaesmann L, Janssen S, Schild SE.

Lung. 2016 May 2. [Epub ahead of print]

PMID:
27140191
3.

Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.

Seidl D, Janssen S, Strojan P, Bajrovic A, Schild SE, Rades D.

Anticancer Res. 2016 May;36(5):2523-6.

PMID:
27127167
4.

Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer.

Seidl D, Janssen S, Strojan P, Hakim SG, Wollenberg B, Schild SE, Rades D.

Anticancer Res. 2016 May;36(5):2487-91.

PMID:
27127162
5.

A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Gebauer N, Bartscht T, Schild SE.

BMC Cancer. 2016 Apr 25;16(1):292. doi: 10.1186/s12885-016-2325-y.

6.

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS; International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):505-16. doi: 10.1016/j.ijrobp.2016.01.036. Epub 2016 Jan 23. Review.

PMID:
27084663
7.

Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer.

Rades D, Janssen S, Käsmann L, Bolm L, Schild SE.

Anticancer Res. 2016 Apr;36(4):2035-9.

PMID:
27069199
8.

Forecasting Survival Probabilities After Radiotherapy of Metastatic Epidural Spinal Cord Compression from Colorectal Cancer in the Elderly.

Rades D, Bartscht T, Janssen S, Bajrovic A, Segedin B, Schild SE.

Anticancer Res. 2016 Apr;36(4):1829-33.

PMID:
27069166
9.
10.

Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer.

Liu W, Patel SH, Shen JJ, Hu Y, Harrington DP, Ding X, Halyard MY, Schild SE, Wong WW, Ezzell GA, Bues M.

Pract Radiat Oncol. 2016 Feb 13. pii: S1879-8500(16)00051-5. doi: 10.1016/j.prro.2016.02.002. [Epub ahead of print]

PMID:
27025166
11.

An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.

Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ.

PLoS One. 2016 Mar 17;11(3):e0151785. doi: 10.1371/journal.pone.0151785. eCollection 2016.

12.

Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.

Käsmann L, Janssen S, Schild SE, Rades D.

Anticancer Res. 2016 Mar;36(3):1089-91.

PMID:
26977003
13.

A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.

Rades D, Dziggel L, Janssen S, Blanck O, Hornung D, Schild SE.

Anticancer Res. 2016 Mar;36(3):1073-6.

PMID:
26977000
14.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.

Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower MC, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2016 Mar;14(3):255-64.

PMID:
26957612
15.

Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer.

Kaesmann L, Janssen S, Schild SE, Rades D.

Lung. 2016 Apr;194(2):295-8. doi: 10.1007/s00408-016-9857-4. Epub 2016 Feb 16.

PMID:
26883133
16.
17.

RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.

Schild SE, Ashman JB, Keole SR, Daniels TB, Rule WG.

J Natl Cancer Inst. 2016 Jan 7;108(3). pii: djv412. doi: 10.1093/jnci/djv412. Print 2016 Mar. No abstract available.

PMID:
26744478
18.

Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).

Rades D, Šegedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE.

J Clin Oncol. 2016 Feb 20;34(6):597-602. doi: 10.1200/JCO.2015.64.0862. Epub 2016 Jan 4.

PMID:
26729431
19.

Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Liu W, Schild SE, Chang JY, Liao Z, Chang YH, Wen Z, Shen J, Stoker JB, Ding X, Hu Y, Sahoo N, Herman MG, Vargas C, Keole S, Wong W, Bues M.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):523-33. doi: 10.1016/j.ijrobp.2015.11.002. Epub 2015 Nov 10.

PMID:
26725727
20.

Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).

Salama JK, Gu L, Wang X, Pang HH, Bogart JA, Crawford J, Schild SE, Vokes EE, Ready NE.

J Thorac Oncol. 2016 Mar;11(3):361-9. doi: 10.1016/j.jtho.2015.11.001. Epub 2015 Dec 24.

PMID:
26723241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk